Apple supplier Pegatron will reportedly make about 15 percent of the iPhone 6 total orders, focusing on the 4.7-inch model of the smartphone.

The next-generation iPhone 6 is widely expected to launch later this year in two large-screen versions, one with a 4.7-inch display and one with a larger 5.5-inch panel. It is one of the most highly-anticipated devices of this year and is expected to launch with top-notch specs and features.

According to a new report from Industrial and Commercial Times (via Macotakara), Pegatron has received 15 percent of the total orders to build the 4.7-inch iPhone 6. The report further notes that Pegatron plans to make 50 million iPhones in total throughout the year, but that amount will reportedly include the iPhone 5C and iPhone 4S, alongside the new iPhone 6.

Previous rumors have indicated that Pegatron would be in charge of making roughly 50 percent of all iPhone 6 orders for Apple, considerably more than the 15 percent mentioned in this latest report. Apple's manufacturing partner Foxconn will likely be in charge of making the majority of iPhone 6 orders.

The report only mentions that Pegatron will make 4.7-inch iPhone 6 units, but doesn't note whether it will be dealing with the larger 5.5-inch model as well. The 4.7-inch iPhone 6 is expected to launch in September, while the larger version should launch before the holiday shopping season, likely in November. Recent reports, however, have suggested that the iPhablet may see some launch delays, as component manufacturers may not be able to meet Apple's demands for a release this year.

The iPhone 6 has starred in numerous rumors so far and has leaked extensively, but so far nothing is confirmed. Rumored specs aside the large display include Apple's next-generation A8 mobile processor with 64-bit architecture, a sapphire glass display, iOS 8, and more. With nothing officially announced or confirmed, however, it's difficult to determine which rumors are accurate and which are pure fantasy.

This latest report is a bit sketchy to say the least, and has no concrete evidence to back it up. Consequently, it is highly advisable to take with a healthy dose of skepticism. We'll keep you up to date as soon as we hear more, so stay tuned.